Source: BondWatch.ai, Date as of May 7, 2025 Amgen Inc. is one of the world’s leading biotechnology companies, dedicated to discovering, developing, and delivering innovative human therapeutics. With a focus on serious and chronic diseases, Amgen leverages cutting-edge science and genetic research to address critical medical needs in oncology, nephrology, cardiovascular disease, autoimmune disorders, and…...